Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomised, DBPC Clinical Trial to Evaluate the Efficacy and Safety of Polymerized and Mannan Conjugated Allergen Extract of Dermatophagoides for the Treatment of Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma

NCT05641272 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT05641272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05641272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomised, DBPC Clinical Trial to Evaluate the Efficacy and Safety of Polymerized and Mannan Conjugated Allergen Extract of Dermatophagoides for the Treatment of Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma
Lead sponsor
Inmunotek S.L.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
November 1, 2023
Completion date
December 1, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma, allergic rhinitis, allergic rhinoconjunctivitis, allergy to house dust mite